Unusual to posit a biotech but Biotron BIT has just announced what looks like a real (yes, I know the word is an unreliable cliche) breakthrough in the treatemnt of AIDS. The big plus is that the drug that is their lead compound has potential against a whole rnge of nasty viruses including Hep C, Flu and dengue fever to name just a few.
Volume is up significantly but, as yet, price has not followed. This is an almost unbelieveable opportunity to get set in a stock which is selling at the same price as it was before we had a successful clinical trial and the latest announcement of HIV success.
